Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 11,689,000 | 11,246,910 | 12,116,000 | 11,067,000 | 11,262,890 |
| Cost of Goods | 2,711,500 | 2,705,000 | 1,677,589 | 2,489,870 | 4,855,310 |
| Gross Profit | 8,872,020 | 8,610,000 | 3,021,590 | 8,577,120 | 17,507,700 |
| Operating Expenses | 5,062,620 | 5,025,000 | 2,389,059 | 5,059,420 | 9,982,870 |
| Operating Income | 3,915,380 | 3,516,910 | 8,049,941 | 3,518,580 | -3,574,980 |
| Other Income | 73,970 | 212,090 | -7,766,752 | 284,940 | 11,592,390 |
| Pre-tax Income | 3,989,350 | 3,729,000 | 283,189 | 3,803,520 | 8,017,410 |
| Income Tax | 1,137,840 | 1,078,000 | 119,060 | 1,083,250 | 2,284,730 |
| Net Income Continuous | 2,600,000 | 2,634,696 | 2,194,000 | 2,720,266 | 2,689,675 |
| Net Income | $2,600,000 | $2,634,696 | $2,194,000 | $2,720,266 | $2,689,675 |
| EPS Basic Total Ops | 1.23 | 1.18 | 0.49 | 1.20 | 1.19 |
| EPS Basic Continuous Ops | 1.23 | 1.18 | 0.49 | 1.20 | 1.19 |
| EPS Diluted Total Ops | 1.23 | 1.18 | 0.49 | 1.20 | 1.19 |
| EPS Diluted Continuous Ops | 1.23 | 1.18 | 0.49 | 1.20 | 1.19 |
| EBITDA(a) | $3,915,380 | $3,516,910 | $6,190,621 | $4,337,760 | $-2,893,781 |